CHPA petitions
This article was originally published in The Tan Sheet
Executive Summary
OTC and supplement labels' use of the phrases "may contain," "may also contain" or "and/or" to list inactive and non-supplement ingredients is requested in two petitions submitted to FDA Sept. 8. CHPA's requests echo a petition submitted by Arnall Golden & Gregory June 2 (1"The Tan Sheet" June 5, p. 4). OTC drug and supplement labeling regs require all companies to list inactives on packaging, but the "specific makeup of composite inactive ingredients can vary slightly from supplier to supplier," CHPA notes, and multiple suppliers are necessary to ensure uninterrupted flow of products. Alerting consumers to potential allergens, a possible advantage to the requirements, is unjustified since consumers can self-select to their needs among the many competing products on the market, the association contends
You may also be interested in...
OTC Inactive Ingredient Labeling Guidance To Be Issued By FDA
FDA plans to issue a guidance to industry on how to list inactive ingredients that may or may not be present in OTC drug labeling
OTC Inactive Ingredient Labeling Guidance To Be Issued By FDA
FDA plans to issue a guidance to industry on how to list inactive ingredients that may or may not be present in OTC drug labeling
OTC Inactive Ingredient Labeling Guidance To Be Issued By FDA
FDA plans to issue a guidance to industry on how to list inactive ingredients that may or may not be present in OTC drug labeling